[LightInTheBox Responds to Class Action Lawsuit Thempany has reviewed the claimsserted in themplaint and believes that they are without merit. While thempany has not yet been served with apy of themplaint, it intends to work with Simpson Thacher & Bartlett its legalunsel, to vigorously defend itself in this matter.]
[CMGE Reports Second Quarter 2013 Unaudited Financial Results HONG KONG, August 28, 2013 China Mobile Games and Entertainment Group Limited (CMGE or the Company) (Nasdaq: CMGE), a leading mobile game company in China, today reported its unaudited financial results for the second quarter ended Second Quarter 2013 Financial Highlights Revenues were RMB72.0 million (US$11.7 million 1 ), 18.6%] [China Mobile Games and Entertainment Group Limited Description]
[This Form 6-K consists of: Contents 2 Interim Results 2 Business Review for the First Half of the Year 3 Prospects for the Second Half of 2013 3 Management’s Discussion and Analysis (Prepared Under IFRS) 12 Share Capital Structure 12 Purchase, Sale or Redemption of Shares 12 Major Shareholding Structure 13 Material Interests and Short Positions in Shares and Underlying]
[FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer] [Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board " (b)de " (c)mmittee Rule 16b-3 Exchange Act " (d)mpany " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grantreement] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China Ladies and Gentlemen:hiff Hardin ex5-1.htm 3 EX-5.1] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8ted August 28, 2013 of Biostar Pharmaceuticals, of our reportted April 11, 2013 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong August 28, 2013 ex23-2.htm 5 EX-23.2]
[Qihoo 360 Technology Co. Ltd. Announces Offering of US$550 Million BEIJING, Aug. 27, 2013 -- Qihoo 360 Technology Co. Ltd. ("Qihoo 360" or the "Company") (NYSE: QIHU) today announced that it plans to offer US$550 million principal amount of convertible senior notes due 2018, subject to market conditions and other factors. Qihoo 360 plans to grant the initial purchasers of] [Technology Co. Ltd. Prices Offering of US$550 Million of Qihoo 360 The notes will be convertible into Qihoo 360’s American Depositary Shares (“ADSs”), every two ADSs representing as of the date above three Class A ordinary shares of Qihoo 360, based on an initial conversion rate of 9.0119 ADSs per US$1,000 principal amount of the notes (equivalent to an initial] []
[FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer] [Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board " (b)de " (c)mmittee Rule 16b-3 Exchange Act " (d)mpany " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grantreement] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China Ladies and Gentlemen:hiff Hardin ex5-1.htm 3 EX-5.1] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8ted August 28, 2013 of Biostar Pharmaceuticals, of our reportted April 11, 2013 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong August 28, 2013 ex23-2.htm 5 EX-23.2]
[SHARE PURCHASE AGREEMENT Agreement Agreement Date Purchaser CAGP CAGP Co-Invest Sellers Seller This SHARE PURCHASE AGREEMENT (the Party Parties Each of the Purchaser and the Sellers is hereinafter referred to individually as a RECITALS WHEREAS Shares Company WHEREAS WHEREAS NOW, THEREFORE ARTICLE I Purchase and Sale of Shares Section 1.01 Sale and Purchase Schedule 1 Purchase Price Section] [Explanatory Note ITEM 2. Identity and Background Item 2 of the Statement is amended and restated in its entirety by inserting the following information: This statement is being filed by the following persons, (each is hereinafter individually referred to as a Reporting Person and collectively as the Reporting Persons.): Carlyle Group Management L.L.C. The Carlyle Group, L.P. Carlyle Holdings II]
[SHARE PURCHASE AGREEMENT Agreement Agreement Date Purchaser CAGP CAGP Co-Invest Sellers Seller This SHARE PURCHASE AGREEMENT (the Party Parties Each of the Purchaser and the Sellers is hereinafter referred to individually as a RECITALS WHEREAS Shares Company WHEREAS WHEREAS NOW, THEREFORE ARTICLE I Purchase and Sale of Shares Section 1.01 Sale and Purchase Schedule 1 Purchase Price Section] [Explanatory Note ITEM 2. Identity and Background Item 2 of the Statement is amended and restated in its entirety by inserting the following information: This statement is being filed by the following persons, (each is hereinafter individually referred to as a Reporting Person and collectively as the Reporting Persons.): Carlyle Group Management L.L.C. The Carlyle Group, L.P. Carlyle Holdings II]
